Talk:Calcium 2-aminoethylphosphate

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Biophysics (inactive)

This article is within the scope of WikiProject Biophysics, a project which is currently considered to be inactive.BiophysicsWikipedia:WikiProject BiophysicsTemplate:WikiProject BiophysicsBiophysics articles

Franz Kohler

I searched if there was a wikipedia article about him, but there are three pages of different people that is not him (Franz Kohler, Franz Köhler and Georges Jean Franz Köhler).

I dig in a bit, and the person most likely to be is Franz Josef Köhler.

"Calcium EAP by Dr Franz Kohler Chemie GmbH". Brewer International Science Library. Archived from the original on 2022-05-12. Retrieved 2022-05-12.

Petillon, Katja (2021-06-22). "Our company". Dr. Franz Köhler Chemie GmbH. Archived from the original on 2022-05-12. Retrieved 2022-05-12.

—Arthurfragoso (talk) 15:03, 12 May 2022 (UTC)[reply]

Notability & Fringe theory templates

I have added notability and fringe templates because I can't find any coverage of this compound in reliable scientific or medical sources, besides a passing mention in a low impact chemistry journal. This compound was patented by someone known for promoting unsafe and alternative treatments, and the National MS society stated in 2006 that the FDA classifies this as an unsafe treatment and stated that it may have serious risk. I will leave the templates for a while, and unless something changes, I believe that this page should be deleted. --Tristario (talk) 11:43, 20 June 2022 (UTC)[reply]